Related Experiment Videos

Clinical studies with silymarin: fibrosis progression is the end point

D Schuppan, E G Hahn

Hepatology (Baltimore, Md.)

|February 15, 2001

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The antifibrotic potential of a sustained release formulation of a PDGFβ-receptor targeted rho kinase inhibitor.

Journal of controlled release : official journal of the Controlled Release Society·2019

IL10 promoter haplotypes may contribute to altered cytokine expression and systemic inflammation in celiac disease.

Clinical immunology (Orlando, Fla.)·2018

Pharmacokinetics of a sustained release formulation of PDGFβ-receptor directed carrier proteins to target the fibrotic liver.

Journal of controlled release : official journal of the Controlled Release Society·2017

The good and the bad collagens of fibrosis - Their role in signaling and organ function.

Advanced drug delivery reviews·2017

Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.

Alimentary pharmacology & therapeutics·2016

Antifibrotic therapies in the liver.

Seminars in liver disease·2015

See all related articles